The U.S. Attorney’s Office in Miami is accusing Illinois-based drugmaker Abbott Laboratories of inflating some pharmaceutical prices 1,000 percent to defraud Medicare and Medicaid of $175 million.
According to the complaint, which was unsealed by U.S. District Judge Alan Gold on Wednesday, Abbott inflated prices for some 40 drugs, solutions and injections, including simple sterile water. The drugmaker ratcheted up prices by as much as 10 times, or 1,000 percent.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
